These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 32364806

  • 1. The pharmacology of antibiotic therapy in hidradenitis suppurativa.
    Marasca C, Tranchini P, Marino V, Annunziata MC, Napolitano M, Fattore D, Fabbrocini G.
    Expert Rev Clin Pharmacol; 2020 May; 13(5):521-530. PubMed ID: 32364806
    [Abstract] [Full Text] [Related]

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I, Brkić J, Ćorluka M, Čović M, Pejić J, Zeljko Penavić J.
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [Abstract] [Full Text] [Related]

  • 3. Unconventional therapies for hidradenitis suppurativa.
    Marasca C, Annunziata MC, Napolitano M, Fabbrocini G.
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):879-887. PubMed ID: 30136871
    [Abstract] [Full Text] [Related]

  • 4. Bacteriology of hidradenitis suppurativa/acne inversa: A review.
    Nikolakis G, Join-Lambert O, Karagiannidis I, Guet-Revillet H, Zouboulis CC, Nassif A.
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S12-8. PubMed ID: 26470608
    [Abstract] [Full Text] [Related]

  • 5. Emerging drugs for the treatment of hidradenitis suppurativa.
    Folkes AS, Hawatmeh FZ, Wong A, Kerdel FA.
    Expert Opin Emerg Drugs; 2020 Sep; 25(3):201-211. PubMed ID: 32667213
    [Abstract] [Full Text] [Related]

  • 6. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC, Preston A, Frieder J, Wang X, Paek SY.
    Dermatology; 2020 Sep; 236(5):413-420. PubMed ID: 31935718
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biologic therapies for the treatment of hidradenitis suppurativa.
    Rosales Santillan M, Morss PC, Porter ML, Kimball AB.
    Expert Opin Biol Ther; 2020 Jun; 20(6):621-633. PubMed ID: 32077334
    [Abstract] [Full Text] [Related]

  • 9. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
    Zouboulis CC, Bechara FG, Fritz K, Goebeler M, Hetzer FH, Just E, Kirsten N, Kokolakis G, Kurzen H, Nikolakis G, Pinter A, Podda M, Rosinski K, Schneider-Burrus S, Taube KM, Volz T, Winkler T, Kristandt A, Presser D, Zouboulis VA.
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):868-889. PubMed ID: 38770982
    [Abstract] [Full Text] [Related]

  • 10. Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa.
    Fischer AH, Haskin A, Okoye GA.
    J Am Acad Dermatol; 2017 Feb; 76(2):309-313.e2. PubMed ID: 27742173
    [Abstract] [Full Text] [Related]

  • 11. The Microbiology of Hidradenitis Suppurativa.
    Ring HC, Emtestam L.
    Dermatol Clin; 2016 Jan; 34(1):29-35. PubMed ID: 26617355
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic Treatment of Hidradenitis Suppurativa.
    Bettoli V, Join-Lambert O, Nassif A.
    Dermatol Clin; 2016 Jan; 34(1):81-9. PubMed ID: 26617361
    [Abstract] [Full Text] [Related]

  • 13. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC, Bechara FG, Dickinson-Blok JL, Gulliver W, Horváth B, Hughes R, Kimball AB, Kirby B, Martorell A, Podda M, Prens EP, Ring HC, Tzellos T, van der Zee HH, van Straalen KR, Vossen ARJV, Jemec GBE.
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [Abstract] [Full Text] [Related]

  • 14. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
    Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, Prignano F.
    Dermatol Ther; 2019 Mar; 32(2):e12792. PubMed ID: 30515931
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T.
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [Abstract] [Full Text] [Related]

  • 19. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD, Cannizzaro MV, Botti E, Di Raimondo C, Di Matteo E, Gaziano R, Bianchi L.
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [Abstract] [Full Text] [Related]

  • 20. Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy.
    Vural S, Gündoğdu M, Akay BN, Boyvat A, Erdem C, Koçyiğit P, Bostancı S, Sanli H, Kundakci N.
    Dermatol Ther; 2019 Sep; 32(5):e13003. PubMed ID: 31237104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.